Recently, the m6A regulator signature (YTHDC2 and ALKBH5) [18] and m6A regulators (YTHDC2 and IGF2BP3) signature [51] were shown to have good predictive performance for OS in CRC. Here, ALKBH5 is linked to colorectal carcinoma.